FIL Ltd - 07 Feb 2023 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Role
Other*
Signature
Stephanie J. Brown, Duly authorized under Powers of Attorney, by and on behalf of FIL Limited, Eight Roads Shareholdings Limited, and its direct and indirect subsidiaries, Eight Roads Holdings Limited and Eight Roads Investments
Issuer symbol
GPCR
Transactions as of
07 Feb 2023
Net transactions value
$0
Form type
4
Filing time
09 Feb 2023, 13:04:59 UTC
Previous filing
02 Feb 2023
Next filing
12 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GPCR Ordinary Shares Conversion of derivative security +4,013,678 4,013,678 07 Feb 2023 Eight Roads Investments F1
transaction GPCR Ordinary Shares Conversion of derivative security +620,499 +15% 4,634,177 07 Feb 2023 Eight Roads Investments F1
transaction GPCR Ordinary Shares Conversion of derivative security +452,867 +9.8% 5,087,044 07 Feb 2023 Eight Roads Investments F1
transaction GPCR Ordinary Shares Conversion of derivative security +179,242 +3.5% 5,266,286 07 Feb 2023 Eight Roads Investments F1
transaction GPCR Ordinary Shares Conversion of derivative security +71,636 71,636 07 Feb 2023 ERVC Healthcare Advisors IV, LP F1
transaction GPCR Ordinary Shares Conversion of derivative security +10,154 +14% 81,790 07 Feb 2023 ERVC Healthcare Advisors IV, LP F1
transaction GPCR Ordinary Shares Conversion of derivative security +7,411 +9.1% 89,201 07 Feb 2023 ERVC Healthcare Advisors IV, LP F1
transaction GPCR Ordinary Shares Conversion of derivative security +494,035 494,035 07 Feb 2023 ERVC Healthcare V, LP F1
transaction GPCR Ordinary Shares Conversion of derivative security +624,239 624,239 07 Feb 2023 ERVC Healthcare IV, LP F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GPCR Series A Convertible Preferred Shares Conversion of derivative security -4,013,678 -100% 0 07 Feb 2023 Ordinary Shares 4,013,678 Eight Roads Investments F1
transaction GPCR Series A+ Convertible Preferred Shares Conversion of derivative security -620,499 -100% 0 07 Feb 2023 Ordinary Shares 620,499 Eight Roads Investments F1
transaction GPCR Series B Convertible Preferred Shares Conversion of derivative security -452,867 -100% 0 07 Feb 2023 Ordinary Shares 452,867 Eight Roads Investments F1
transaction GPCR Series B-1 Convertible Preferred Shares Conversion of derivative security -179,242 -100% 0 07 Feb 2023 Ordinary Shares 179,242 Eight Roads Investments F1
transaction GPCR Series A Convertible Preferred Shares Conversion of derivative security -71,636 -100% 0 07 Feb 2023 Ordinary Shares 71,636 ERVC Healthcare Advisors IV, LP F1
transaction GPCR Series A+ Convertible Preferred Shares Conversion of derivative security -10,154 -100% 0 07 Feb 2023 Ordinary Shares 10,154 ERVC Healthcare Advisors IV, LP F1
transaction GPCR Series B Convertible Preferred Shares Conversion of derivative security -7,411 -100% 0 07 Feb 2023 Ordinary Shares 7,411 ERVC Healthcare Advisors IV, LP F1
transaction GPCR Series B-1 Convertible Preferred Shares Conversion of derivative security -494,035 -100% 0 07 Feb 2023 Ordinary Shares 494,035 ERVC Healthcare V, LP F1
transaction GPCR Series A Convertible Preferred Shares Conversion of derivative security -624,239 -100% 0 07 Feb 2023 Ordinary Shares 624,239 ERVC Healthcare IV, LP F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

FIL Ltd is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On February 7, 2023, in connection with the completion of the issuer's initial public offering, each share of Series A, A+, B, and B-1 Preferred Shares converted on a 1-for-1 basis into Ordinary Shares.

Remarks:

Remark 1:Eight Roads Shareholdings Limited ("ERSL") and Pandanus Partners, LP ("Pandanus") own shares of Eight Roads Holdings Limited ("ERHL") voting stock. ERHL is the immediate parent company of Eight Roads Investments ("ERI"), which owns the shares being reported on with this Form. While the percentage of total voting power represented by ERSL's and Pandanus' shares of ERHL voting stock may fluctuate due to changes in the total number of shares of ERHL voting stock outstanding from time to time, ERSL's holdings represents more than 50% and Pandanus' holding represents more than 25% and less than 50% of, the total votes which may be cast by all holders of ERHL voting stock. The shares in ERSL are owned primarily by officers and senior employees of FIL Limited and Eight Roads together with several charitable organizations. No such person or organization owns or controls more than 25% of the voting stock in ERSL. Pandanus Associates, Inc. ("PAI")acts as general partner of Pandanus. Pandanus is owned by trusts for the benefit of members of the Johnson family, including ERHL's Chairman Abigail P. Johnson, but disclaims that any such member is a beneficial owner of the securities reported on this form. The address of ERSL, ERHL and ERI is 42 Crow Lane, Hamilton HM19, Bermuda. The address of Pandanus is c/o FIL Limited, 42 Crow Lane, Hamilton HM19, Bermuda. The address of PAI is 11 Keewaydin Drive, Suite 100, Salem, NH, USA, 03079. ERVC Healthcare IV, LP and ERVC Healthcare V, LP (Collectively "ERVC HC") are limited partners. The General Partners of ERVC HC are ERVC Healthcare Advisors V, LP and ERVC Healthcare Advisors IV, LP (collectively "ERVC HCA").The general partner of ERVC HCA is Eight Roads GP, which is controlled by ERSL. Remark 2:The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein.